GHP Investment Advisors’s GT Biopharma GTBP Stock Holding History

GHP Investment Advisors’s Portfolio GTBP Stock Details GTBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33	Closed	-$71	–	978
2025 Q1	$71	Buy	+33	New	+$78	﹤0.01%	944

Other funds holding GTBP

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

GHP Investment Advisors's GTBP Position: Q2 2025 in Review

GHP Investment Advisors sold out of GT Biopharma (GTBP) in Q2 2025, closing a stake of 33 shares — an estimated $71 sold.

GHP Investment Advisors first reported a position in GTBP in Q1 2025 and held it in 1 quarter. The position peaked at $71 in Q1 2025. 21 funds tracked by Wall St. Rank hold GTBP as of Q2 2025.

GHP Investment Advisors reported no remaining GT Biopharma position as of Q2 2025 after selling out during the quarter.
GHP Investment Advisors sold 33 GT Biopharma shares in Q2 2025, an estimated $71.
GHP Investment Advisors first reported a position in GT Biopharma in Q1 2025 and held it in 1 quarter.
GHP Investment Advisors's GT Biopharma position peaked at $71 in Q1 2025.
21 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2025.

Based on GHP Investment Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.